Literature DB >> 28174023

Hydrogen sulfide in stroke: Protective or deleterious?

Su Jing Chan1, Peter T-H Wong2.   

Abstract

Hydrogen sulfide is believed to be a signalling molecule in the central nervous system. It is known to increase rapidly following an ischemic insult in experimental stroke. Is it protective or deleterious? This review surveys the relevant information available in the literature. It appears that there is no definitive answer to this question at present. Current evidence seems to suggest that the presence of H2S in the ischemic brain may either be deleterious or protective depending on its concentration, deleterious when high and protective when low. Therefore, it can be inferred that either an enhancement or a reduction of its concentration may be of potential use in future stroke therapy.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hydrogen sulphide; Neuroprotection; Stroke; Toxic effect

Mesh:

Substances:

Year:  2017        PMID: 28174023     DOI: 10.1016/j.neuint.2016.11.015

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  13 in total

1.  L-Cysteine attenuates osteopontin-mediated neuroinflammation following hypoxia-ischemia insult in neonatal mice by inducing S-sulfhydration of Stat3.

Authors:  Ting-Ting Li; Dan-Qing Xin; Hong-Fei Ke; Xi-Li Chu; Yi-Jing Zhao; Shou-Wei Yue; De-Xiang Liu; Zhen Wang
Journal:  Acta Pharmacol Sin       Date:  2021-11-04       Impact factor: 7.169

2.  Hydrogen Sulfide: a Novel Immunoinflammatory Regulator in Rheumatoid Arthritis.

Authors:  M Li; Jian-Chun Mao; Yi-Zhun Zhu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  A Novel Liposomal S-Propargyl-Cysteine: A Sustained Release of Hydrogen Sulfide Reducing Myocardial Fibrosis via TGF-β1/Smad Pathway.

Authors:  Yicheng Mao; Yi Zhun Zhu; Ba Hieu Tran; Ying Yu; Lingling Chang; Bo Tan; Wanwan Jia; Ying Xiong; Tao Dai; Rui Zhong; Weiping Zhang; Van Minh Le; Peter Rose; Zhijun Wang
Journal:  Int J Nanomedicine       Date:  2019-12-24

4.  L-Cysteine Provides Neuroprotection of Hypoxia-Ischemia Injury in Neonatal Mice via a PI3K/Akt-Dependent Mechanism.

Authors:  Tingting Li; Jiangbing Li; Tong Li; Yijing Zhao; Hongfei Ke; Shuanglian Wang; Dexiang Liu; Zhen Wang
Journal:  Drug Des Devel Ther       Date:  2021-02-11       Impact factor: 4.162

Review 5.  Hydrogen sulfide therapy in brain diseases: from bench to bedside.

Authors:  Ju-Yi Zhang; Yi-Ping Ding; Zhong Wang; Yan Kong; Rong Gao; Gang Chen
Journal:  Med Gas Res       Date:  2017-06-30

6.  The Mycoplasma pneumoniae HapE alters the cytokine profile and growth of human bronchial epithelial cells.

Authors:  Shaoli Li; Guanhua Xue; Hanqing Zhao; Yanling Feng; Chao Yan; Jinghua Cui; Hongmei Sun
Journal:  Biosci Rep       Date:  2019-01-18       Impact factor: 3.840

Review 7.  Hydrogen Sulfide and Endoplasmic Reticulum Stress: A Potential Therapeutic Target for Central Nervous System Degeneration Diseases.

Authors:  Huimin Zhong; Huan Yu; Junjue Chen; Jun Sun; Lei Guo; Ping Huang; Yisheng Zhong
Journal:  Front Pharmacol       Date:  2020-05-14       Impact factor: 5.810

8.  Hydrogen Sulfide Attenuates β2-Microglobulin-Induced Cognitive Dysfunction: Involving Recovery of Hippocampal Autophagic Flux.

Authors:  Si-Min Chen; Yi-Li Yi; Dan Zeng; Yi-Yun Tang; Xuan Kang; Ping Zhang; Wei Zou; Xiao-Qing Tang
Journal:  Front Behav Neurosci       Date:  2019-10-25       Impact factor: 3.558

9.  Neuroprotective effect of hydrogen sulfide against glutamate-induced oxidative stress is mediated via the p53/glutaminase 2 pathway after traumatic brain injury.

Authors:  Jianping Sun; Xiaoyu Li; Xiaoyu Gu; Hailong Du; Gengshen Zhang; Jianliang Wu; Feng Wang
Journal:  Aging (Albany NY)       Date:  2021-02-26       Impact factor: 5.682

10.  Intravenous hydrogen sulfide does not induce neuroprotection after aortic balloon occlusion-induced spinal cord ischemia/reperfusion injury in a human-like porcine model of ubiquitous arteriosclerosis.

Authors:  Andre Bredthauer; Karla Lehle; Angelika Scheuerle; Hubert Schelzig; Oscar McCook; Peter Radermacher; Csaba Szabo; Martin Wepler; Florian Simon
Journal:  Intensive Care Med Exp       Date:  2018-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.